Development of pet imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel h-NOX oxygen carrier
Ended Project Grant Awarded Last action
- Award ID
- R01CA204723
- Recipient
-
Omniox Inc. UEI MERZH84KMHM6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,860,127
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Funding
-
- $3,799,424.37 Federal
- $1,060,703.00 Non-federal
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$57,753 | $0 | |
| Amendment | $522,676 | $0 | |
| Amendment | $522,676 | $522,676 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $538,027 | $0 | |
| Amendment | $538,027 | $538,027 | |
| Amendment | $704 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $546,766 | $0 | |
| Amendment | $585,583 | $0 | |
| Original award | $602,718 | $0 |
Show all 15
Quick answers
Who received award R01CA204723?
R01CA204723 was awarded to Omniox Inc. by National Cancer Institute (National Institutes of Health) on May 1, 2017.
How much is award R01CA204723 worth?
$4,860,127 has been obligated on R01CA204723: $3,799,424 in federal funding and $1,060,703 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award